Lfcr investors have opportunity to lead lifecore biomedical, inc. securities fraud lawsuit

Los angeles , aug. 30, 2024 /prnewswire/ -- glancy prongay & murray llp ("gpm") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against lifecore biomedical, inc. ("lifecore" or the "company") (nasdaq: lfcr). class period: october 7, 2020 – march 19, 2024 lead plaintiff deadline: september 27, 2024 if you wish to serve as lead plaintiff of the lifecore lawsuit, you can submit your contact information at www.glancylaw.com/cases/lifecore-biomedical-inc/.
LFCR Ratings Summary
LFCR Quant Ranking